DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
80.24
-0.33 (-0.41%)
At close: Dec 27, 2024, 4:00 PM
80.27
+0.03 (0.04%)
After-hours: Dec 27, 2024, 5:09 PM EST
DexCom Revenue
DexCom had revenue of $994.20M in the quarter ending September 30, 2024, with 1.97% growth. This brings the company's revenue in the last twelve months to $3.95B, up 16.19% year-over-year. In the year 2023, DexCom had annual revenue of $3.62B with 24.49% growth.
Revenue (ttm)
$3.95B
Revenue Growth
+16.19%
P/S Ratio
7.95
Revenue / Employee
$411,875
Employees
9,600
Market Cap
31.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.62B | 712.50M | 24.49% |
Dec 31, 2022 | 2.91B | 461.30M | 18.84% |
Dec 31, 2021 | 2.45B | 521.80M | 27.08% |
Dec 31, 2020 | 1.93B | 450.70M | 30.54% |
Dec 31, 2019 | 1.48B | 444.40M | 43.08% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 224.45B |
Centene | 146.20B |
Humana | 115.01B |
GE HealthCare Technologies | 19.56B |
ResMed | 4.81B |
IDEXX Laboratories | 3.84B |
Mettler-Toledo International | 3.76B |
BioNTech SE | 3.39B |
DXCM News
- 3 days ago - Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown - CNBC
- 4 days ago - DexCom, Abbott Agree to Settlement in Patent Litigation - WSJ
- 4 days ago - Abbott and DexCom settle glucose monitor patent disputes - Reuters
- 8 days ago - Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement - Business Wire
- 10 days ago - Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels - CNBC
- 10 days ago - Dexcom Launches the First Generative AI Platform in Glucose Biosensing - Business Wire
- 10 days ago - Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM - Business Wire
- 17 days ago - DexCom: Brighter 2025 From Stelo Ramp - Seeking Alpha